{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:10:13Z","timestamp":1771488613176,"version":"3.50.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00923","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T13:57:27Z","timestamp":1557928647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB\/c Mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Athina","family":"Kilpel\u00e4inen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narc\u00eds","family":"Saubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Guitart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathifa","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund G.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krupa","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"B1","unstructured":"GHO | By category | Antiretroviral Therapy Coverage - Data and Estimates by WHO Region."},{"key":"B2","volume-title":"WHO | TB and HIV Factsheet 2016.","year":"2018"},{"key":"B3","volume-title":"WHO | BCG Vaccine.","year":"2018"},{"key":"B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-1157(88)90025-X","article-title":"The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine","volume":"16","author":"Gheorghiu","year":"1988","journal-title":"J Biol Stand."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/574591","article-title":"Mycobacterium bovis Bacille Calmette-gu\u00e9rin as a vaccine vector for global infectious disease control","volume":"2011","author":"Matsuo","year":"2011","journal-title":"Tuberc Res Treat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1586\/14760584.5.6.827","article-title":"Progress towards an HIV vaccine based on recombinant Bacillus Calmette\u2013Gu\u00e9rin: failures and challenges","volume":"5","author":"Joseph","year":"2006","journal-title":"Expert Rev Vaccines."},{"key":"B7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1073\/pnas.85.6.1917","article-title":"Immunological significance of Mycobacterium leprae cell walls","volume":"85","author":"Melancon-Kaplan","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.micpath.2005.03.003","article-title":"Mycobacterial trehalose 6,6'-dimycolate preferentially induces type 1 helper T cell responses through signal transducer and activator of transcription 4 protein","volume":"39","author":"Oiso","year":"2005","journal-title":"Microb Pathog."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1099\/mic.0.27791-0","article-title":"Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry","volume":"151","author":"Fujita","year":"2005","journal-title":"Microbiology."},{"key":"B10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science."},{"key":"B11","first-page":"27","article-title":"BCG vaccine. WHO position paper","volume":"79","year":"2004","journal-title":"Relev Epidemiol Hebd."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1016\/J.VACCINE.2018.03.009","article-title":"BCG vaccine: WHO position paper, February 2018 \u2013 recommendations","volume":"36","year":"2018","journal-title":"Vaccine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1073\/pnas.1501443112","article-title":"Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial","volume":"112","author":"Kuebler","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/JVI.80.6.3122-3125.2006","article-title":"Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control","volume":"80","author":"Zu\u00f1iga","year":"2006","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/infdis\/jit322","article-title":"Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection","volume":"208","author":"Janes","year":"2013","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1172\/JCI4314","article-title":"Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi","volume":"102","author":"Rowland-Jones","year":"1998","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity","volume":"79","author":"Ami","year":"2005","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e42559","DOI":"10.1371\/journal.pone.0042559","article-title":"Pre-clinical development of BCG.HIVACAT, an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG","volume":"7","author":"Saubi","year":"2012","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1128\/JVI.00707-07","article-title":"Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding","volume":"81","author":"Im","year":"2007","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1128\/JVI.02607-09","article-title":"Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques","volume":"84","author":"Rosario","year":"2010","journal-title":"J Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/79626","article-title":"Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya","volume":"6","author":"Hanke","year":"2000","journal-title":"Nat Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1080\/21645515.2017.1316911","article-title":"Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity","volume":"13","author":"Mahant","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"L\u00e9tourneau","year":"2007","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e101591","DOI":"10.1371\/journal.pone.0101591","article-title":"Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial","volume":"9","author":"Hayton","year":"2014","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"21171","DOI":"10.7448\/IAS.20.1.21171","article-title":"Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects","volume":"20","author":"Hancock","year":"2017","journal-title":"J Int AIDS Soc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/mt.2016.3","article-title":"Novel conserved-region t-cell mosaic vaccine with high global HIV-1 coverage is recognized by protective responses in untreated infection","volume":"24","author":"Ondondo","year":"2016","journal-title":"Mol Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/0264-410X(00)00369-8","article-title":"Identification of substrains of BCG vaccine using multiplex PCR","volume":"19","author":"Bedwell","year":"2001","journal-title":"Vaccine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/157016210791208686","article-title":"Recombinant Mycobacterium bovis BCG as an HIV vaccine vector","volume":"8","author":"Chapman","year":"2010","journal-title":"Curr HIV Res."},{"key":"B32","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/JB.181.16.4780-4789.1999","article-title":"Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37RV by allelic exchange","volume":"181","author":"Pavelka","year":"1999","journal-title":"J Bacteriol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1073\/pnas.88.8.3111","article-title":"Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Gu\u00e9rin","volume":"88","author":"Lee","year":"1991","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.omtm.2019.01.014","article-title":"MTBVAC based TB-HIV vaccine is safe, elicits HIV-T cell responses and protects against Mycobacterium tuberculosis in mice","volume":"13","author":"Broset","year":"2019","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"357370","DOI":"10.1155\/2010\/357370","article-title":"Molecular characterization of heterologous HIV-1gp120 gene expression disruption in Mycobacterium bovis BCG host strain: a critical issue for engineering Mycobacterial based-vaccine vectors","volume":"2010","author":"Joseph","year":"2010","journal-title":"J Biomed Biotechnol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.161.6.2985","article-title":"The MHC class I-restricted immune response to HIV-gag in BALB\/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D","volume":"161","author":"Mata","year":"1998","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymthe.2016.12.004","article-title":"HIV-1 conserved mosaics delivered by regimens with integration-deficient DC-targeting lentiviral vector induce robust T cells","volume":"25","author":"Wee","year":"2017","journal-title":"Mol Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1128\/CVI.00587-14","article-title":"Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB\/c mice","volume":"21","author":"Ondondo","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.4049\/jimmunol.172.6.3491","article-title":"Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes","volume":"172","author":"van Faassen","year":"2004","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.omtm.2018.10.010","article-title":"Efficient induction of T cells against conserved HIV-1 regions by mosaic vaccines delivered as self-amplifying mRNA","volume":"12","author":"Moyo","year":"2019","journal-title":"Mol Ther - Methods Clin Dev."},{"key":"B41","unstructured":"25646119Global HIV & AIDS Statistics \u2014 2018 fact sheet | UNAIDS.2018"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1038\/mtm.2014.17","article-title":"Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG","volume":"1","author":"Saubi","year":"2014","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jbiotec.2008.01.011","article-title":"Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli","volume":"134","author":"Vidal","year":"2008","journal-title":"J Biotechnol."},{"key":"B44","year":"","journal-title":"Guide- Line on Quality, Non-clinical and Clinical Aspects of Live Recombinant Viral Vectored Vaccines."},{"key":"B45","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1128\/CVI.00075-15","article-title":"Stable expression of lentiviral antigens by quality-controlled recombinant mycobacterium bovis BCG vectors","volume":"22","author":"Hart","year":"2015","journal-title":"Clin Vaccine Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/14760584.2018.1534588","article-title":"Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned","volume":"17","author":"Kilpel\u00e4inen","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1128\/IAI.02100-14","article-title":"Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responses","volume":"82","author":"Panas","year":"2014","journal-title":"Infect Immun."},{"key":"B48","first-page":"191","article-title":"The effects of dispersed or surface grown cultures, manufacture and control methods on BCG standardization","volume":"58","author":"Gheorghiu","year":"1986","journal-title":"Dev Biol Stand."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/516219","article-title":"Newborn mice vaccination with BCG.HIVA 222 + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes","volume":"2011","author":"Saubi","year":"2011","journal-title":"Clin Dev Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/351479a0","article-title":"Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines","volume":"351","author":"Aldovini","year":"1991","journal-title":"Nature."},{"key":"B51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/JVI.01269-06","article-title":"Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis","volume":"81","author":"Hovav","year":"2007","journal-title":"J Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.vaccine.2009.05.064","article-title":"A prime\u2013boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons","volume":"27","author":"Chege","year":"2009","journal-title":"Vaccine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1128\/CVI.00324-14","article-title":"Recombinant Mycobacterium bovis bacillus calmette-guerin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques","volume":"21","author":"Sixsmith","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1128\/JVI.80.4.1645-1652.2006","article-title":"Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env","volume":"80","author":"Cayabyab","year":"2006","journal-title":"J Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1080\/21645515.2017.1383575","article-title":"Chimpanzee adenoviral vectors as vaccines for outbreak pathogens","volume":"13","author":"Ewer","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B57","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.1998.00702.x","article-title":"Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD","volume":"114","author":"Sasiain","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell\u2013mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","author":"Bruns","year":"2009","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T16:05:43Z","timestamp":1694880343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2019.00923"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00923","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"article-number":"923"}}